Karyopharm Therapeutics (KPTI) PT Lowered to $7 at Piper Sandler
Tweet
Share
E-mailGet Alerts KPTI Hot Sheet
Price: $1.78 -3.78%
Rating Summary:
11 Buy, 6 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Rating Summary:
11 Buy, 6 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Join SI Premium – FREE
Piper Sandler analyst Edward A. Tenthoff lowered the price target on Karyopharm Therapeutics (NASDAQ: KPTI) to $7.00 (from $16.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Braze Inc (BRZE) PT Raised to $40 at DA Davidson
- MongoDB (MDB) PT Raised to $500 at Monness, Crespi, Hardt
- Palo Alto Networks (PANW) PT Raised to $410 at Piper Sandler
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
